Selective ATP competitive sphingosine kinase 2 and 1 (SphK2/1) inhibitor (Ki
values are 6.9 and 27 μ
M, respectively). Exhibits selectivity for SphK 1 and 2 over other kinases. Inhibits cellular S1P production and increases sphingosine and ceramide levels in vitro
. Also induces mitochondrial-associated apoptosis. Reduces tumor growth in a human lung adenocarcinoma xenograft mouse model, by inducing apoptosis and suppressing angiogenesis. Cell permeable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.
Pitman et al.